Distinct roles of class IA PI3K isoforms in primary and immortalised macrophagesEvangelia A. Papakonstanti, Bart Vanhaesebroeck, Antonio Bilancio et al.|Journal of Cell Science|2008Cited by 94
A combined opposite targeting of p110δ PI3K and RhoA abrogates skin cancerNiki Tzenaki, Evangelia A. Papakonstanti|Communications Biology|2024Cited by 2
IOA-244, a novel p110δ PI3K inhibitor, blocks breast tumour progression on either mono- or combined-therapyEvangelia Goulielmaki, Evangelia A. Papakonstanti|Cell Death Discovery|2026Cited by 0